Clearance rates of total prostate specific antigen (PSA) after radical prostatectomy in African-Americans and Caucasians

Prostate Cancer and Prostatic Diseases

Volumn 5, Issue 2, 2002, Pages 111-114

  Lotan, Y ^a   Roehrborn, C G ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Elimination kinetic; Ethnicity; PSA; PSA metabolism; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BLOOD ANALYSIS; CANCER LOCALIZATION; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; HALF LIFE TIME; HUMAN; KIDNEY FUNCTION; KINETICS; LINEAR REGRESSION ANALYSIS; LIVER FUNCTION; MALE; METABOLIC CLEARANCE RATE; NEGRO; ORGAN WEIGHT; PATIENT SELECTION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY; RACE DIFFERENCE; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; COMPARATIVE STUDY; ETHNOLOGY; FOLLOW UP; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; REGRESSION ANALYSIS;

AGED; CAUCASOID RACE; COMPARATIVE STUDY; FOLLOW-UP STUDIES; HALF-LIFE; HUMAN; MALE; MIDDLE AGE; NEGROID RACE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MIDDLE AGED;

EID: 0035996406     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500567     Document Type: Article

References (21)

1. Prostate cancer in the African-American: Is this a different disease?
2. Clinical characteristics in black and white men with prostate cancer in an equal access medical center
3. Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients
4. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men
5. Age-specific reference ranges for prostate-specific antigen in black men
6. Prostate specific antigen and pathological features of prostate cancer in black and white patients: A comparative study based on radical prostatectomy specimens
7. Prostate specific antigen: A decade of discovery-what we have learned and where we are going
8. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
9. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy
10. Clearance rate of serum-free and total PSA following radical retropubic prostatectomy
11. Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum
12. ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: Proof of new complex forming of PSA after release into circulation
13. Clearance of free and total serum PSA after prostatic surgery
14. Prostate specific antigen is metabolized in the liver
15. Determination of the site of metabolism of total, free, and complexed prostate-specific antigen
16. Clearance mechanism of prostate specific antigen and its complexes with alpha2-macroglobulin and alpha1-antichymotrypsin
17. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males
18. Results of a study to correlate serum prostate specific antigen and reproductive hormone levels in patients with localized prostate cancer
19. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer
20. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting
21. The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: A multivariate analysis of positive surgical margins